Investigating quality of life in patients suffering from end-stage renal disease with a special focus on psychological distress

Zeitschrift fur Medizinische Psychologie

Volumn 11, Issue 3, 2002, Pages 113-120

  Franke, Gabriele Helga ^a   Reimer, Jens ^b   Hessel, Aike ^c   Philipp, Thomas ^d   Heemann, Uwe ^d  

^a UNIVERSITY OF APPLIED SCIENCES MAGDEBURG STENDAL   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

End stage renal disease; Psychodiagnostic approach; Quality of life

Indexed keywords

EID: 85013606922     PISSN: 09405569     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Aaronson, N.K., Acquadro, C., Alonso, J., Apolone, G., Bucquet, D., Bullinger, M., Bungay, K., Fukuhara, S., Gandek, B., Keller, S., Razavi, D., Sanson-Fisher, R., Sullivan, M., Wood-Dauphinee, S. (1992). International quality of life assessment (ILQA) project. Quality of Life Research, 1, 349-351.
2. Barrett, B.J., Vavasour, H.M., Major, A. & Parfrey, P.S. (1990). Clinical and psychological correlates of somatic symptoms in patients on dialysis. Nephron, 55, 10-15.
3. Becker, G., Franke, G.H., Witzke, O., Philipp, Th. & Heemann, U. (1996). Psychische Auswirkungen einer Nierentransplantation. Transplantationsmedizin, 8, 88-91.
4. Bergner, M., Bobbitt, R.A., Carter, W.B. & Gilson, B.S. (1981). The sickness impact profile: Development and final revision of a health status measure. Medical Care, 19, 787-805.
5. Bullinger, M. & Kirchberger, I. (1998). SF-36 Fragebogen zum Gesundheitszustand, Handanweisung. Göttingen: Hogrefe.
6. Burton, P.R. & Walls, J. (1987). Selection-adjusted comparison of life-expectancy of patients on continous ambulatory peritoneal dialysis, haemodialysis, and renal transplantation. Lancet, 1, 1115-1119.
7. Campbell, A., Converse, P.E. & Rodger, W.L. (1976). The quality of American life. New York: Russell Sage Foundation.
8. Corry, R.J. & Zehr, P. (1990). Quality of life in diabetic recipients of kidney transplants is better with the addition of the pancreas. Clinical Transplantation, 4, 238-241.
9. Deniston, O.L., Carpentier-Alting, P., Kneisley, J., Hawthorne, V.M. & Port, F.K. (1989). Assessment of quality of life in end-stage renal disease. Health Services Research, 24, 555-578.
10. Derogatis, L.R. & Melisaratos, N. (1983). The Brief Symptom Inventory: An introductory report. Psychological Medicine, 13, 595-605.
11. Dew, A.M. & Simmons, R.G. (1990). The advantage of multiple measures of quality of life. Scandinavian Journal of Urology and Nephrology, 131, 23-30.
12. Dew, M.A., Switzer, G.E., Goycoolea, J.M., Allen, A.S., DiMartini, A., Kormos, R.L. & Griffith, B.P. (1997). Does transplantation produce quality of life benefits? Transplantation, 64, 1261-1273.
13. De Witt, G.A., Ramsteijn, P.G. & De Charro, F.T. (1998). Economic evaluation of end stage renal diseas treatment. Health Policy, 44, 215-232.
14. Essink-Bot, M.L., Krabbe, P.F.M., van Agt, H.M.E. & Bonsel, G.J. (1996). NHP or SIP: A comparative study in renal insufficiency associated anemia. Quality of Life Research, 5, 91-100.
15. Evans, R.W. (1991). Recombinant human erythropoietin and the quality of life of end-stage renal disease patients: A comparative analysis. American Journal of Kidney Diseases, 18, 62-70.
16. Franke, G.H. (1997). Erste Studien zur Güte des Brief Symptom Inventory (BSI). Zeitschrift für Medizinische Psychologie, 6, 159-166.
17. Franke, G.H. (1999). Effekte der Computeradministration bei der Symptom-Checkliste (SCL-90-R) unter besonderer Berücksichtigung der Itemreihenfolge. Diagnostica, 45, 147-153.
18. Franke, G.H. (2000). BSI. Brief Symptom Inventory - Deutsche Version. Manual. Göttingen: Beltz.
19. Franke, G.H. (2001). Möglichkeiten und Grenzen im Einsatz der SCL-90-R. Verhaltenstherapie & psychosoziale Praxis, 33, 475-485.
20. Franke, G.H., Becker, G., Binek, M., Heemann, U. & Philipp, T. (1998). Die Münchener-Lebensqualitäts-Dimensionen Liste (MLDL) im Einsatz bei Patienten vor und nach einer Nierentransplantation. Zeitschrift für Medizinische Psychologie, 7, 40-45.
21. Franke, G.H., Heemann, U., Kohnle, M., Luetkes, P., Maehner, N. & Reimer, J. (2000b). Quality of life in patients before and after kidney transplantation. Psychology and Health, 14, 1037-1049.
22. Franke, G.H., Reimer, J., Lütkes, P., Kohnle, M., Gerken, G., Philipp, T. & Heemann, U. (2000c). Die ESRD Symptom Checklist - Transplantation Module (ESRD-SCLTM) - ein diagnostisches Verfahren zur Erfassung der krankheitsspezifischen Lebensqualität von Patienten nach Nierentransplantation. Nieren- und Hochdruckkrankheiten, im Druck.
23. Franke, G.H., Reimer, J., Kohnle, M., Luetkes, P., Maehner, N. & Heemann, U. (1999). Quality of life in end-stage renal disease patients after successful kidney transplantation - Development of the ESRD Symptom Checklist Transplantation Module. Nephron, 83, 31-39.
24. Frazier, P.A., Davis-Ali, S.H. & Dahl, K.E. (1995). Stressors, social support, and adjustment in kidney transplant patients and their spouses. Social Work in Health Care, 21, 93-108.
25. Frei, U., Schober-Halstenberg, H.-J. and the QuaSi-Niere Task Group for Quality Assurance in Renal Replacement Therapy. (1999). Annual report of the German Renal Registry 1998. Nephrology, Dialysis, Transplantation, 14, 1085-1090.
26. Furberg, C.D. (1985). Assessment of quality of life. In Fundamentals of clinical trials (pp. 161-170). Littletown: PSG Publishing Co.
27. Garcia, G., Deddens, J.A. & D’Achiardi-Rey, R. (1985). Results of treatment in patients with endstage renal diesease: a multi-variate analysis of risk factors and survival in 341 successive patients. Journal of Kidney Diseases, 5, 10-18.
28. Gjertson, D.W., Cecka, M. & Terasaki, P.I. (1995). The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival. Transplantation, 60, 1384-1388.
29. Hart, L.G. & Evans, R.W. (1987). The functional status of ESRD patients as measured by the Sickness Impact Profile. Journal of Chronic Disease, 40, 117S-130S.
30. Hays, R.D., Vickrey, B.G., Hermann, B.P., Perrine, K., Cramer, J., Meador, K., Spritzer, K. & Devinsky, O. (1995). Agreement between self reports and proxy reports of quality of life in epilepsy patients. Quality of Life Research, 4, 159-168.
31. Heemann, U., Reimer, J., Franke, G.H. & Philipp, T. (2000). Qualitätssicherung in der Nierentransplantation:"Der Essener Ansatz". Der Kassenarzt, eingereicht.
32. Hunt, S.M., McKenna, S.P., McEwen, J., Williams, J. & Papp, E. (1981). The Nottingham Health Profile: Subjective health status and medical consultations. Social Science and Medicine, 15, 221-229.
33. Hutchinson, T.A., Thomas, D.C, Lemieux, J.C. & Harvey, C.E. (1984). Prognostically controlled comparison of dialysis and renal transplantation. Kidney International, 26, 44-51.
34. Karlberg, I. & Nyberg, G. (1995). Cost-effectiveness studies of renal transplantation. International Journal of Technological Assessment in Health Care, 11, 611-622.
35. Kaplan De-Nour, A. & Brickman, A.L. (1996). Determining quality of life in the renal replacement therapies. In Quality of Life and Pharmacoeconomics in Clinical Trials (pp. 953-960). Philadelphia: Lippincott-Raven.
36. Kohlmann, T., Bullinger, M. & Kirchberger-Blumstein, I. (1997). Die deutsche Version des Nottingham Health Profile (NHP): Übersetzungsmethodik und psychometrische Validierung. Sozial- und Präventivmedizin, 42, 175-185.
37. Kurtin, P. & Nissenson, A.R. (1993). Variation in end-stage renal disease patient outcomes: What we know, what should we know, and how do we find it out? Journal of the American Society of Nephrology, 3, 1738-1747.
38. Laupacis, A., Wong, C., Churchill, D. & the Canadian Erythropoietin Study Group (1991). The use of generic and specific quality-of-life measures in hemodialysis patients treated with erythropoietin. Controlled Clinical Trials, 12 (Suppl.), 168-179.
39. Laupacis, A., Keown, P., Pus, N., Krueger, H., Ferguson, B., Wong, C. & Murihead, N. (1996). A study of the quality of life and cost-utility of renal transplantation. Kidney International, 50, 235-242.
40. Levy, N.B., Blumenfield, M., Beasley, C.M., Dubey, A.K., Solomon, R.J., Todd, R., Goddman, A. & Bergstrom R.R. (1996). Fluoxetine in depressed patients with renal failure and in depressed patients with normal kidney function. General Hospital Psychiatry, 18, 8-13.
41. Luetkes, P., Franke, G.H., Witzke, O., Zimmerman, U., Kohnle, M., Heemann, U. & Philipp, T. (1999). Lebensqualität nach Nierentransplantation: Einfluß neuer immunsuppressiver Substanzen. Zentralblatt für Chirurgie, 124, 90-94.
42. McCauley, J., Irish, W., Thompson, L., Stevenson, J., Lockett, R., Bussard, R. & Washington, M. (1997). Factors determining the rate of referral, transplantation, and survival on dialysis in women with ESRD. American Journal of Kidney Diseases, 30, 739-748.
43. Medin, C., Elinder, C.G., Hylander, B., Blom, B. & Wilczek, H. (2000). Survival of patients who have been on a waiting list for renal transplantation. Nephrology, Dialysis, Transplantation, 15, 701-704.
44. Port, F.K., Wolfe, R.A., Mauger, E.A., Berling, D.P. & Jiang, K. (1993). Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. Journal of the American Medical Association, 270, 1339-1343.
45. Rebollo, P., Ortega, F., Baltar, J.M., Badia, X., Alvarez-Ude, F., Diaz-Corte, C., Naves, M., Navascues, R.A., Urena, A. & Alvarez-Grande, J. (2000). Health related quality of life (HRLQ) of kidney transplanted patients: Variables that influence it. Clinical Transplantation, 14, 199-207.
46. Reimer, J., Franke, G.H., Luetkes, P., Kohnle, M., Gerken, G., Philipp, T. & Heemann, U. (2001). Quality of life after kidney transplantation - the impact of Tacrolimus. Transplantation Proceedings, 33, 1924-1926.
47. Sayag, R., Kaplan De-Nour, A., Shapira, Z., Kahan, E. & Boner, G. (1990). Comparison of psychosocial adjustment of male nondiabetic kidney transplant and hospital hemodialysis patients. Nephron, 54, 214-218.
48. Schag, C.C., Heinrich, R.L. & Ganz, P.A. (1984). Karnofsky performance status revisited: Reliability, validity and guidelines. Journal of Clinical Oncology, 2, 187-193.
49. Sensky, T. (1988). Measurement of the quality of life in end-stage renal failure. New England Journal of Medicine, 319, 1353.
50. Simmons, R.G., Anderson, C.R. & Abress, L.K. (1990). Quality of life and rehabilitation differences among four end-stage renal disease therapy groups. Scandinavian Journal of Urology and Nephrology, 131, 7-22.
51. Soskolne, V. & Kaplan De-Nour, A. (1989). The psychosocial adjustment of patients and spouses to dialysis treatment. Social Science and Medicine, 29, 497-502.
52. Spilker, B. (Ed.). (1996). Quality of life and pharmacoeconomics in clinical trials (2nd ed.). Philadelphia: Lippincott-Raven.
53. Steinbüchel, N.v., Bullinger, M. & Kirchberger, I. (1999). Die Münchener Lebensqualitäts-Dimen sionen-Liste (MLDL): Entwicklung und Prüfung eines Verfahrens zu krankheitsübergreifender Erfassung von Lebensqualität. Zeitschrift für Medizinische Psychologie, 8, 99-112.
54. WHOLQ-Group. (1994). The development of the WHO quality of life assessment instruments (WHOLQ). In Quality of life assessment: International perspectives (pp. 41-57). Berlin: Springer.
55. Wight, J.P., Edwards, L., Brazier, J., Walters, S., Payne, J.N. & Brown, C.B. (1998). The SF-36 as an outcome measure of services for end stage renal failure. Quality in Health Care, 7, 209-221.
56. Witzke, O., Becker, G., Franke, G.H., Binek, M., Philipp, T. & Heemann, U. (1997). Kidney transplantation improves quality of life. Transplantation Proceedings, 29, 1569-1570.